{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:48:00Z","timestamp":1759938480472},"reference-count":27,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.jns.2011.12.016","type":"journal-article","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T10:39:01Z","timestamp":1326710341000},"page":"150-157","source":"Crossref","is-referenced-by-count":18,"title":["Neurophysiological characteristics of MuSK antibody positive Myasthenia Gravis mice: Focal denervation and hypersensitivity to acetylcholinesterase inhibitors"],"prefix":"10.1016","volume":"316","author":[{"given":"Elisabeth","family":"Chroni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2011.12.016_bb0005","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.12.016_bb0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1552-6569.2009.00456.x","article-title":"MRI Evidence of Early Muscle Atrophy in MuSK Positive Myasthenia Gravis","volume":"21","author":"Zouvelou","year":"2011","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.jns.2011.12.016_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2011.12.016_bb0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.20498","article-title":"Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis","volume":"33","author":"Oh","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2011.12.016_bb0025","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1069::AID-MUS1>3.0.CO;2-Y","article-title":"AAEM minimonograph #25: single-fiber electromyography","volume":"19","author":"Sanders","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2011.12.016_bb0030","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.12.016_bb0035","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.12.016_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.20515","article-title":"Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody","volume":"34","author":"Punga","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2011.12.016_bb0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/mus.20935","article-title":"Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis","volume":"37","author":"Punga","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2011.12.016_bb0050","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1476-5381.1986.tb14594.x","article-title":"Mechanisms of the inhibition by neostigmine of tetanic contraction in the mouse diaphragm","volume":"87","author":"Chang","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jns.2011.12.016_bb0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2006.03.016","article-title":"Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)","volume":"175","author":"Jha","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2011.12.016_bb0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.neuroscience.2006.09.022","article-title":"Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis","volume":"143","author":"Xu","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2011.12.016_bb0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.08.016","article-title":"MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo","volume":"170","author":"Benveniste","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2011.12.016_bb0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice","volume":"230","author":"Punga","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jns.2011.12.016_bb0075","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.4049\/jimmunol.177.8.5296","article-title":"Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells","volume":"177","author":"Sheng","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2011.12.016_bb0080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clim.2008.03.509","article-title":"Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis","volume":"128","author":"Sheng","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jns.2011.12.016_bb0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1084\/jem.151.1.204","article-title":"Experimental myasthenia gravis. A murine system","volume":"151","author":"Berman","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2011.12.016_bb0090","first-page":"231","article-title":"Tetanic fade induced by d-Tubocurarine, Hexamethonium and Neostigmine in phrenic nerve diaphragm of diabetic rats","volume":"20","author":"Tagliari","year":"1986","journal-title":"Acta Sci"},{"key":"10.1016\/j.jns.2011.12.016_bb0095","doi-asserted-by":"crossref","first-page":"36835","DOI":"10.1074\/jbc.M607887200","article-title":"Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin","volume":"281","author":"Scotton","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2011.12.016_bb0100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2011.12.016_bb0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.wco.0000180660.57801.3f","article-title":"Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis","volume":"18","author":"Vincent","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jns.2011.12.016_bb0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1212\/WNL.39.4.561","article-title":"End-plate dysfunction in acute organophosphate intoxication","volume":"39","author":"Besser","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.12.016_bb0115","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1127::AID-MUS7>3.0.CO;2-1","article-title":"Repetitive CMAPs: mechanisms of neural and synaptic genesis","volume":"19","author":"van Dijk","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2011.12.016_bb0120","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1460-9568.2010.07569.x","article-title":"MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity","volume":"33","author":"Punga","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jns.2011.12.016_bb0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1405.012","article-title":"Response to therapy in myasthenia gravis with anti-MuSK antibodies","volume":"1132","author":"Evoli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jns.2011.12.016_bb0130","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.wnl.0000183145.91579.74","article-title":"Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG","volume":"65","author":"Hatanaka","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.12.016_bb0135","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1213\/00000539-199610000-00031","article-title":"Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state","volume":"83","author":"Scheller","year":"1996","journal-title":"Anesth Analg"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11007532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11007532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T02:25:55Z","timestamp":1543285555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X11007532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":27,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0022510X11007532"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2011.12.016","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}